SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-218050
Filing Date
2022-08-11
Accepted
2022-08-11 08:26:33
Documents
14
Period of Report
2022-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d385983d8k.htm   iXBRL 8-K 24022
2 EX-99.1 d385983dex991.htm EX-99.1 51633
6 GRAPHIC g385983g87f68.jpg GRAPHIC 9160
  Complete submission text file 0001193125-22-218050.txt   222567

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA etnb-20220811.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20220811_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20220811_pre.xml EX-101.PRE 11704
8 EXTRACTED XBRL INSTANCE DOCUMENT d385983d8k_htm.xml XML 3464
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 221153822
SIC: 2834 Pharmaceutical Preparations